**Introduction** In 2012, MERS-CoV was identified in Saudi Arabia and resulted in more than 2442 confirmed cases worldwide by May 2019. MERS-CoV infection in children is less common. A review of MERS-CoV in children from 2012 to April 2016 summarized the clinical manifestation of 31 reported cases. Most children were asymptomatic or had mild respiratory symptoms, and severe infection reported in patients with comorbid conditions. We aimed to study the clinical characteristics of pediatric MERS CoV infected cases in UAE supported by literature review.

**Method** A retrospective multicenter chart review study was conducted for MERS-CoV cases in Abu Dhabi Emirate (May 2012 -- May 2019). Demographic, clinical and laboratory data were analyzed. We reviewed WHO outbreak surveillance reports published online to identify pediatric MERS-CoV cases from April 2016 to June 2019.

**Results** We describe favorable outcomes of MERS-CoV infection in three children identified in UAE. Two patients had household contact with MERS-CoV infected family members and another patient travelled to Saudi Arabia. MERS-CoV was confirmed by PCR from nasopharyngeal aspirates and duration of viral shedding ranged from 4 to 11 days. One patient was asymptomatic and other two had mild respiratory symptoms. Laboratory data and chest X rays were normal.

We reviewed WHO surveillance data and identified 11 pediatric MERS-CoV cases from April 2016 to June 2019. Mean age of 14.9 years (6 females, 5 males). The majority of pediatric outbreak was in year 2017 (8 cases) and most cases identified in Saudi Arabia. The main risk factor was household infection. Two patients died due to severe MERS-CoV infection. There are an estimated 42 pediatric MERS-CoV cases reported globally, with a mortality rate of 9.5 % (4 cases).

**Conclusion** Pediatric MERS-CoV infection is acquired mainly through household contact. It has favorable outcomes and the mortality rate in children remains lower than adults.
